| Year | Q2 2024 | Q1 2024 |
|---|---|---|
| Total Revenue | 4.62B | 4.46B |
| Cost of Revenue | 1.74B | 2.87B |
| Gross Profit | 2.88B | 1.59B |
| Operating Expenses | 2.88B | 1.24B |
| Research and Development | 0 | 257.14M |
| Selling, General & Administrative Expenses | 0 | 984.87M |
| Selling & Marketing Expenses | 0 | 0 |
| General & Administrative Expenses | 0 | 0 |
| Other Expenses | 2.88B | 0 |
| Operating Income | 0 | 1.62B |
| Total Other Income/Expenses Net | 329.9M | -1.47B |
| Income Before Tax | 329.9M | 149.99M |
| Income Tax | 25M | 57.43M |
| Net Income | 304.9M | 92.56M |
| Basic EPS | 4.34 | 1.31 |
| EPS Diluted | 4.32 | 1.31 |
| Basic Average Shares | 70.25M | 70.66M |
| Diluted Average Shares | 70.58M | 70.66M |
| EBITDA | 663.2M | 434.98M |
Unichem Laboratories Limited
UNICHEMLAB.NS
NSE
570.85INR14.35 (-5.37%)
UNICHEMLAB.NS Financial Statements
Retained Earning Schedule
| Year |
|---|
| Retained Earnings (Previous Year) |
| Net Income |
| Stock Repurchases |
| Dividend Paid |
| Retained Earnings |
| Other Distributions |
PPE Schedule
| Year |
|---|
| Gross PPE |
| Annual Depreciation |
| Capital Expenditure |
| Net PPE |
Intangible and Goodwill Schedule
| Year |
|---|
| Acquisitions and Adjustments |
| Goodwill (Previous Year) |
| Goodwill |